サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1742539

医師調剤コスメシューティカル市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測

Physician Dispensed Cosmeceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025-2035

出版日
ページ情報
英文 251 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
医師調剤コスメシューティカル市場：世界の産業分析、規模、シェア、成長、動向、2025～2035年予測
出版日: 2025年04月23日
発行: Transparency Market Research
ページ情報: 英文 251 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

医師調剤コスメシューティカル市場- 調査範囲

TMRの調査レポート「医師調剤コスメシューティカルの世界市場」は、2025～2035年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。当レポートでは、2025年を基準年、2035年を予測年として、2019～2035年までの世界の医師調剤コスメシューティカル市場の収益と予測を提供します。また、2025～2035年までの世界の医師調剤コスメシューティカル市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されています。1次調査では、アナリストが主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。2次調査では、主要企業の製品資料、アニュアルレポート、プレスリリース、関連資料などを参照し、医師調剤コスメシューティカル市場を推察しました。

市場スナップショット
2024年の市場規模 207億米ドル
2035年の市場規模 446億米ドル
CAGR 7.1%

当レポートでは、世界の医師調剤コスメシューティカル市場の競合情勢について調査しています。世界の医師調剤コスメシューティカル市場で事業を展開する主要企業が特定され、各企業が様々な属性でプロファイルされています。企業概要、財務状況、最近の動向、SWOTが本レポートで紹介されている世界の医師調剤コスメシューティカル市場におけるプレイヤーの属性です。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

  • イントロダクション
  • 概要
  • 市場力学
  • 世界の医師調剤コスメシューティカル市場分析と予測、2020～2035年

第5章 主要洞察

  • 技術的進歩
  • 主要製品/ブランド分析
  • 主要な業界動向
  • 地域別/世界全体の規制シナリオ
  • ポーターのファイブフォース分析
  • PESTEL分析
  • 化粧品と薬用化粧品におけるナノテクノロジーに関する洞察
  • 医師調剤コスメシューティカル製品の消費者行動パターン分析

第6章 世界の市場分析と予測：製品タイプ別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：製品タイプ別、2020～2035年
    • スキンケア製品
      • アンチエイジング製品
      • ニキビ治療製品
      • 肌の美白と色素沈着
      • ボツリヌス毒素
      • 皮膚充填剤
      • その他
    • ヘアケア製品
      • ヘアリペア
      • フケ防止
      • 抜け毛防止
      • 頭皮リペア
      • その他
    • アイケア製品
    • その他
  • 市場の魅力：製品タイプ別

第7章 世界の市場分析と予測：投与経路別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：投与経路別、2020～2035年
    • 経口
    • 局所
    • 非経口
    • その他
  • 市場の魅力：投与経路別

第8章 世界の市場分析と予測：性別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：性別、2020～2035年
    • 男性
    • 女性
  • 市場の魅力：性別

第9章 世界の市場分析と予測：処方別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：処方別、2020～2035年
    • 錠剤
    • カプセル
    • ローション
    • 注射剤
    • その他
  • 市場の魅力：処方別

第10章 世界の市場分析と予測：流通チャネル別

  • イントロダクションと定義
  • 主な調査結果/進展
  • 市場金額予測：流通チャネル別、2020～2035年
    • 皮膚科クリニック
    • メディカルスパ
    • 皮膚科のある病院
    • ウェルネスセンター
    • 小売薬局
    • オンラインプラットフォーム
  • 市場の魅力：流通チャネル別

第11章 世界の市場分析と予測：地域別

  • 主な調査結果
  • 市場金額予測：地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力：地域別

第12章 北米の市場分析と予測

  • 米国
  • カナダ

第13章 欧州の市場分析と予測

  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州地域

第14章 アジア太平洋地域の市場分析と予測

  • 中国
  • インド
  • 日本
  • オーストラリアとニュージーランド
  • その他アジア太平洋地域

第15章 ラテンアメリカの市場分析と予測

  • ブラジル
  • メキシコ
  • その他ラテンアメリカ地域

第16章 中東・アフリカの市場分析と予測

  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

第17章 競合情勢

  • 市場企業-競合マトリックス（企業階層別・規模別）
  • 市場シェア分析企業別（2024）
  • 企業プロファイル
    • AbbVie Inc.（Allergan）
    • L'Oreal S.A.（Skinbetter Science）
    • Jan Marini Skin Research, Inc.
    • Athena Cosmetics, Inc.
    • ZO Skin Health Inc.
    • Galderma Laboratories, L.P.
    • Procter & Gamble Co.
    • The Estee Lauder Companies, Inc.
    • Merz Pharma
    • Obagi Cosmeceuticals LLC
    • iS CLINICAL
    • Velius, LLC
    • Sonoma Pharmaceuticals, Inc.
    • Sientra, Inc.
    • Dynamic Techno Medicals
    • Bausch Health Companies Inc.
図表

List of Tables

  • Table 01: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Product Type, 2020-2035
  • Table 02: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Skincare Products, 2020-2035
  • Table 03: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Hair Care Products, 2020-2035
  • Table 04: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 05: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 06: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 07: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 08: Global Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Region, 2020-2035
  • Table 09: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country, 2020-2035
  • Table 10: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 11: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 12: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 13: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 14: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 15: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 16: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 17: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 18: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 19: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 20: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 21: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 22: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 23: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 24: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 25: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 26: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 27: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 28: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 29: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 30: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 31: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 32: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 33: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 34: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 35: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 36: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 37: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 38: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 39: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 40: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035
  • Table 41: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020-2035
  • Table 42: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Product Type, 2020-2035
  • Table 43: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Skincare Products, 2020-2035
  • Table 44: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, by Hair Care Products, 2020-2035
  • Table 45: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Route of Administration, 2020-2035
  • Table 46: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Gender, 2020-2035
  • Table 47: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Formulation, 2020-2035
  • Table 48: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, By Distribution Channel, 2020-2035

List of Figures

  • Figure 01: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 02: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 03: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Skincare Products, 2020-2035
  • Figure 04: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Hair Care Products, 2020-2035
  • Figure 05: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Eye Care Products, 2020-2035
  • Figure 06: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 07: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 08: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 09: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Oral, 2020-2035
  • Figure 10: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Topical, 2020-2035
  • Figure 11: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Parenteral, 2020-2035
  • Figure 12: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 13: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 14: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 15: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Male, 2020-2035
  • Figure 16: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Female, 2020-2035
  • Figure 17: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 18: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 19: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Tablet, 2020-2035
  • Figure 20: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Capsule, 2020-2035
  • Figure 21: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Lotion, 2020-2035
  • Figure 22: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Injectable, 2020-2035
  • Figure 23: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Others, 2020-2035
  • Figure 24: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 25: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 26: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Dermatology Clinics, 2020-2035
  • Figure 27: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Medical Spas, 2020-2035
  • Figure 28: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Hospitals with Dermatology Departments, 2020-2035
  • Figure 29: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Wellness Centers, 2020-2035
  • Figure 30: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Retail Pharmacies, 2020-2035
  • Figure 31: Global Physician Dispensed Cosmeceuticals Market Revenue (US$ Bn), by Online Platforms, 2020-2035
  • Figure 32: Global Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 33: Global Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Region, 2025-2035
  • Figure 34: North America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 35: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 36: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country, 2025-2035
  • Figure 37: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 38: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 39: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 40: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 41: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 42: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 43: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 44: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 45: North America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 46: North America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 47: Europe - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 48: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 49: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 50: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 51: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 52: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 53: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 54: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 55: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 56: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 57: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 58: Europe - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 59: Europe - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 60: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 61: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 62: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 63: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 64: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 65: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 66: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 67: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 68: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 69: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 70: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 71: Asia Pacific - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 72: Asia Pacific - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 73: Latin America - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 74: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 75: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 76: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 77: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 78: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 79: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 80: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 81: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 82: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 83: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 84: Latin America - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 85: Latin America - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
  • Figure 86: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value (US$ Bn) Forecast, 2020-2035
  • Figure 87: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 88: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, by Country/Sub-region, 2025-2035
  • Figure 89: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Product Type, 2024 and 2035
  • Figure 90: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Product Type, 2025-2035
  • Figure 91: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Route of Administration, 2024 and 2035
  • Figure 92: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Route of Administration, 2025-2035
  • Figure 93: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Gender, 2024 and 2035
  • Figure 94: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Gender, 2025-2035
  • Figure 95: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Formulation, 2024 and 2035
  • Figure 96: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Formulation, 2025-2035
  • Figure 97: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Value Share Analysis, By Distribution Channel, 2024 and 2035
  • Figure 98: Middle East and Africa - Physician Dispensed Cosmeceuticals Market Attractiveness Analysis, By Distribution Channel, 2025-2035
目次
Product Code: TMRGL565

Physician Dispensed Cosmeceuticals Market - Scope of Report

TMR's report on the global physician dispensed cosmeceuticals market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global physician dispensed cosmeceuticals market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global physician dispensed cosmeceuticals market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the physician dispensed cosmeceuticals market.

Market Snapshot
Market Value in 2024US$ 20.7 Bn
Market Value in 2035US$ 44.6 Bn
CAGR7.1%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global physician dispensed cosmeceuticals market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global physician dispensed cosmeceuticals market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global physician dispensed cosmeceuticals market.

The report delves into the competitive landscape of the global physician dispensed cosmeceuticals market. Key players operating in the global physician dispensed cosmeceuticals market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global physician dispensed cosmeceuticals market profiled in this report.

Key Questions Answered in global physician dispensed cosmeceuticals Market Report:

  • What is the sales/revenue generated by physician dispensed cosmeceuticals across all regions during the forecast period?
  • What are the opportunities in the global physician dispensed cosmeceuticals market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Physician Dispensed Cosmeceuticals Market - Research Objectives and Research Approach

The comprehensive report on the global physician dispensed cosmeceuticals market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global physician dispensed cosmeceuticals market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global physician dispensed cosmeceuticals market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Research Methodology

3. Executive Summary: Global Physician Dispensed Cosmeceuticals Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, 2020-2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Key Product/Brand Analysis
  • 5.3. Key Industry Developments
  • 5.4. Regulatory Scenario by Region/globally
  • 5.5. Porter's Five Forces Analysis
  • 5.6. PESTEL Analysis
  • 5.7. Insights on Nanotechnology in Cosmetics and Cosmeceuticals
  • 5.8. Consumer Behavior Patterns Analysis for Physician Dispensed Cosmeceuticals Products

6. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Product Type, 2020-2035
    • 6.3.1. Skincare Products
      • 6.3.1.1. Anti-aging Products
      • 6.3.1.2. Acne treatment Products
      • 6.3.1.3. Skin Whitening and Hyperpigmentation
      • 6.3.1.4. Botulinum Toxin
      • 6.3.1.5. Dermal fillers
      • 6.3.1.6. Others
    • 6.3.2. Hair Care Products
      • 6.3.2.1. Hair Repair
      • 6.3.2.2. Anti-dandruff
      • 6.3.2.3. Anti-hair Fall
      • 6.3.2.4. Scalp Repair
      • 6.3.2.5. Others
    • 6.3.3. Eye Care Products
    • 6.3.4. Others
  • 6.4. Market Attractiveness By Product Type

7. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Route of Administration

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Route of Administration, 2020-2035
    • 7.3.1. Oral
    • 7.3.2. Topical
    • 7.3.3. Parenteral
    • 7.3.4. Others
  • 7.4. Market Attractiveness By Route of Administration

8. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Gender

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By Gender, 2020-2035
    • 8.3.1. Male
    • 8.3.2. Female
  • 8.4. Market Attractiveness By Gender

9. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Formulation

  • 9.1. Introduction & Definition
  • 9.2. Key Findings / Developments
  • 9.3. Market Value Forecast By Formulation, 2020-2035
    • 9.3.1. Tablet
    • 9.3.2. Capsule
    • 9.3.3. Lotion
    • 9.3.4. Injectable
    • 9.3.5. Others
  • 9.4. Market Attractiveness By Formulation

10. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings / Developments
  • 10.3. Market Value Forecast By Distribution Channel, 2020-2035
    • 10.3.1. Dermatology Clinics
    • 10.3.2. Medical Spas
    • 10.3.3. Hospitals with Dermatology Departments
    • 10.3.4. Wellness Centers
    • 10.3.5. Retail Pharmacies
    • 10.3.6. Online Platforms
  • 10.4. Market Attractiveness By Distribution Channel

11. Global Physician Dispensed Cosmeceuticals Market Analysis and Forecasts, By Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast By Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness By Region

12. North America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Product Type, 2020-2035
    • 12.2.1. Skincare Products
      • 12.2.1.1. Anti-aging Products
      • 12.2.1.2. Acne treatment Products
      • 12.2.1.3. Skin Whitening and Hyperpigmentation
      • 12.2.1.4. Dermal fillers
      • 12.2.1.5. Others
    • 12.2.2. Hair Care Products
      • 12.2.2.1. Hair Repair
      • 12.2.2.2. Anti-dandruff
      • 12.2.2.3. Anti-hair Fall
      • 12.2.2.4. Scalp Repair
      • 12.2.2.5. Others
    • 12.2.3. Eye Care Products
    • 12.2.4. Others
  • 12.3. Market Value Forecast By Route of Administration, 2020-2035
    • 12.3.1. Oral
    • 12.3.2. Topical
    • 12.3.3. Parenteral
    • 12.3.4. Others
  • 12.4. Market Value Forecast By Gender, 2020-2035
    • 12.4.1. Male
    • 12.4.2. Female
  • 12.5. Market Value Forecast By Formulation, 2020-2035
    • 12.5.1. Tablet
    • 12.5.2. Capsule
    • 12.5.3. Lotion
    • 12.5.4. Injectable
    • 12.5.5. Others
  • 12.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 12.6.1. Dermatology Clinics
    • 12.6.2. Medical Spas
    • 12.6.3. Hospitals with Dermatology Departments
    • 12.6.4. Wellness Centers
    • 12.6.5. Retail Pharmacies
    • 12.6.6. Online Platforms
  • 12.7. Market Value Forecast By Country, 2020-2035
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Product Type
    • 12.8.2. By Route of Administration
    • 12.8.3. By Gender
    • 12.8.4. By Formulation
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Product Type, 2020-2035
    • 13.2.1. Skincare Products
      • 13.2.1.1. Anti-aging Products
      • 13.2.1.2. Acne treatment Products
      • 13.2.1.3. Skin Whitening and Hyperpigmentation
      • 13.2.1.4. Botulinum Toxin
      • 13.2.1.5. Dermal fillers
      • 13.2.1.6. Others
    • 13.2.2. Hair Care Products
      • 13.2.2.1. Hair Repair
      • 13.2.2.2. Anti-dandruff
      • 13.2.2.3. Anti-hair Fall
      • 13.2.2.4. Scalp Repair
      • 13.2.2.5. Others
    • 13.2.3. Eye Care Products
    • 13.2.4. Others
  • 13.3. Market Value Forecast By Route of Administration, 2020-2035
    • 13.3.1. Oral
    • 13.3.2. Topical
    • 13.3.3. Parenteral
    • 13.3.4. Others
  • 13.4. Market Value Forecast By Gender, 2020-2035
    • 13.4.1. Male
    • 13.4.2. Female
  • 13.5. Market Value Forecast By Formulation, 2020-2035
    • 13.5.1. Tablet
    • 13.5.2. Capsule
    • 13.5.3. Lotion
    • 13.5.4. Injectable
    • 13.5.5. Others
  • 13.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 13.6.1. Dermatology Clinics
    • 13.6.2. Medical Spas
    • 13.6.3. Hospitals with Dermatology Departments
    • 13.6.4. Wellness Centers
    • 13.6.5. Retail Pharmacies
    • 13.6.6. Online Platforms
  • 13.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Italy
    • 13.7.5. Spain
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Product Type
    • 13.8.2. By Route of Administration
    • 13.8.3. By Gender
    • 13.8.4. By Formulation
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Product Type, 2020-2035
    • 14.2.1. Skincare Products
      • 14.2.1.1. Anti-aging Products
      • 14.2.1.2. Acne treatment Products
      • 14.2.1.3. Skin Whitening and Hyperpigmentation
      • 14.2.1.4. Botulinum Toxin
      • 14.2.1.5. Dermal fillers
      • 14.2.1.6. Others
    • 14.2.2. Hair Care Products
      • 14.2.2.1. Hair Repair
      • 14.2.2.2. Anti-dandruff
      • 14.2.2.3. Anti-hair Fall
      • 14.2.2.4. Scalp Repair
      • 14.2.2.5. Others
    • 14.2.3. Eye Care Products
    • 14.2.4. Others
  • 14.3. Market Value Forecast By Route of Administration, 2020-2035
    • 14.3.1. Oral
    • 14.3.2. Topical
    • 14.3.3. Parenteral
    • 14.3.4. Others
  • 14.4. Market Value Forecast By Gender, 2020-2035
    • 14.4.1. Male
    • 14.4.2. Female
  • 14.5. Market Value Forecast By Formulation, 2020-2035
    • 14.5.1. Tablet
    • 14.5.2. Capsule
    • 14.5.3. Lotion
    • 14.5.4. Injectable
    • 14.5.5. Others
  • 14.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 14.6.1. Dermatology Clinics
    • 14.6.2. Medical Spas
    • 14.6.3. Hospitals with Dermatology Departments
    • 14.6.4. Wellness Centers
    • 14.6.5. Retail Pharmacies
    • 14.6.6. Online Platforms
  • 14.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 14.7.1. China
    • 14.7.2. India
    • 14.7.3. Japan
    • 14.7.4. Australia & New Zealand
    • 14.7.5. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Product Type
    • 14.8.2. By Route of Administration
    • 14.8.3. By Gender
    • 14.8.4. By Formulation
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast By Product Type, 2020-2035
    • 15.2.1. Skincare Products
      • 15.2.1.1. Anti-aging Products
      • 15.2.1.2. Acne treatment Products
      • 15.2.1.3. Skin Whitening and Hyperpigmentation
      • 15.2.1.4. Botulinum Toxin
      • 15.2.1.5. Dermal fillers
      • 15.2.1.6. Others
    • 15.2.2. Hair Care Products
      • 15.2.2.1. Hair Repair
      • 15.2.2.2. Anti-dandruff
      • 15.2.2.3. Anti-hair Fall
      • 15.2.2.4. Scalp Repair
      • 15.2.2.5. Others
    • 15.2.3. Eye Care Products
    • 15.2.4. Others
  • 15.3. Market Value Forecast By Route of Administration, 2020-2035
    • 15.3.1. Oral
    • 15.3.2. Topical
    • 15.3.3. Parenteral
    • 15.3.4. Others
  • 15.4. Market Value Forecast By Gender, 2020-2035
    • 15.4.1. Male
    • 15.4.2. Female
  • 15.5. Market Value Forecast By Formulation, 2020-2035
    • 15.5.1. Tablet
    • 15.5.2. Capsule
    • 15.5.3. Lotion
    • 15.5.4. Injectable
    • 15.5.5. Others
  • 15.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 15.6.1. Dermatology Clinics
    • 15.6.2. Medical Spas
    • 15.6.3. Hospitals with Dermatology Departments
    • 15.6.4. Wellness Centers
    • 15.6.5. Retail Pharmacies
    • 15.6.6. Online Platforms
  • 15.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Product Type
    • 15.8.2. By Route of Administration
    • 15.8.3. By Gender
    • 15.8.4. By Formulation
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Physician Dispensed Cosmeceuticals Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast By Product Type, 2020-2035
    • 16.2.1. Skincare Products
      • 16.2.1.1. Anti-aging Products
      • 16.2.1.2. Acne treatment Products
      • 16.2.1.3. Skin Whitening and Hyperpigmentation
      • 16.2.1.4. Botulinum Toxin
      • 16.2.1.5. Dermal fillers
      • 16.2.1.6. Others
    • 16.2.2. Hair Care Products
      • 16.2.2.1. Hair Repair
      • 16.2.2.2. Anti-dandruff
      • 16.2.2.3. Anti-hair Fall
      • 16.2.2.4. Scalp Repair
      • 16.2.2.5. Others
    • 16.2.3. Eye Care Products
    • 16.2.4. Others
  • 16.3. Market Value Forecast By Route of Administration, 2020-2035
    • 16.3.1. Oral
    • 16.3.2. Topical
    • 16.3.3. Parenteral
    • 16.3.4. Others
  • 16.4. Market Value Forecast By Gender, 2020-2035
    • 16.4.1. Male
    • 16.4.2. Female
  • 16.5. Market Value Forecast By Formulation, 2020-2035
    • 16.5.1. Tablet
    • 16.5.2. Capsule
    • 16.5.3. Lotion
    • 16.5.4. Injectable
    • 16.5.5. Others
  • 16.6. Market Value Forecast By Distribution Channel, 2020-2035
    • 16.6.1. Dermatology Clinics
    • 16.6.2. Medical Spas
    • 16.6.3. Hospitals with Dermatology Departments
    • 16.6.4. Wellness Centers
    • 16.6.5. Retail Pharmacies
    • 16.6.6. Online Platforms
  • 16.7. Market Value Forecast By Country/Sub-region, 2020-2035
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Product Type
    • 16.8.2. By Route of Administration
    • 16.8.3. By Gender
    • 16.8.4. By Formulation
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 17.2. Market Share Analysis By Company (2024)
  • 17.3. Company Profiles
    • 17.3.1. AbbVie Inc. (Allergan)
      • 17.3.1.1. Company Overview
      • 17.3.1.2. Financial Overview
      • 17.3.1.3. Product Portfolio
      • 17.3.1.4. Business Strategies
      • 17.3.1.5. Recent Developments
    • 17.3.2. L'Oreal S.A. (Skinbetter Science)
      • 17.3.2.1. Company Overview
      • 17.3.2.2. Financial Overview
      • 17.3.2.3. Product Portfolio
      • 17.3.2.4. Business Strategies
      • 17.3.2.5. Recent Developments
    • 17.3.3. Jan Marini Skin Research, Inc.
      • 17.3.3.1. Company Overview
      • 17.3.3.2. Financial Overview
      • 17.3.3.3. Product Portfolio
      • 17.3.3.4. Business Strategies
      • 17.3.3.5. Recent Developments
    • 17.3.4. Athena Cosmetics, Inc.
      • 17.3.4.1. Company Overview
      • 17.3.4.2. Financial Overview
      • 17.3.4.3. Product Portfolio
      • 17.3.4.4. Business Strategies
      • 17.3.4.5. Recent Developments
    • 17.3.5. ZO Skin Health Inc.
      • 17.3.5.1. Company Overview
      • 17.3.5.2. Financial Overview
      • 17.3.5.3. Product Portfolio
      • 17.3.5.4. Business Strategies
      • 17.3.5.5. Recent Developments
    • 17.3.6. Galderma Laboratories, L.P.
      • 17.3.6.1. Company Overview
      • 17.3.6.2. Financial Overview
      • 17.3.6.3. Product Portfolio
      • 17.3.6.4. Business Strategies
      • 17.3.6.5. Recent Developments
    • 17.3.7. Procter & Gamble Co.
      • 17.3.7.1. Company Overview
      • 17.3.7.2. Financial Overview
      • 17.3.7.3. Product Portfolio
      • 17.3.7.4. Business Strategies
      • 17.3.7.5. Recent Developments
    • 17.3.8. The Estée Lauder Companies, Inc.
      • 17.3.8.1. Company Overview
      • 17.3.8.2. Financial Overview
      • 17.3.8.3. Product Portfolio
      • 17.3.8.4. Business Strategies
      • 17.3.8.5. Recent Developments
    • 17.3.9. Merz Pharma
      • 17.3.9.1. Company Overview
      • 17.3.9.2. Financial Overview
      • 17.3.9.3. Product Portfolio
      • 17.3.9.4. Business Strategies
      • 17.3.9.5. Recent Developments
    • 17.3.10. Obagi Cosmeceuticals LLC
      • 17.3.10.1. Company Overview
      • 17.3.10.2. Financial Overview
      • 17.3.10.3. Product Portfolio
      • 17.3.10.4. Business Strategies
      • 17.3.10.5. Recent Developments
    • 17.3.11. iS CLINICAL
      • 17.3.11.1. Company Overview
      • 17.3.11.2. Financial Overview
      • 17.3.11.3. Product Portfolio
      • 17.3.11.4. Business Strategies
      • 17.3.11.5. Recent Developments
    • 17.3.12. Velius, LLC
      • 17.3.12.1. Company Overview
      • 17.3.12.2. Financial Overview
      • 17.3.12.3. Product Portfolio
      • 17.3.12.4. Business Strategies
      • 17.3.12.5. Recent Developments
    • 17.3.13. Sonoma Pharmaceuticals, Inc.
      • 17.3.13.1. Company Overview
      • 17.3.13.2. Financial Overview
      • 17.3.13.3. Product Portfolio
      • 17.3.13.4. Business Strategies
      • 17.3.13.5. Recent Developments
    • 17.3.14. Sientra, Inc.
      • 17.3.14.1. Company Overview
      • 17.3.14.2. Financial Overview
      • 17.3.14.3. Product Portfolio
      • 17.3.14.4. Business Strategies
      • 17.3.14.5. Recent Developments
    • 17.3.15. Dynamic Techno Medicals
      • 17.3.15.1. Company Overview
      • 17.3.15.2. Financial Overview
      • 17.3.15.3. Product Portfolio
      • 17.3.15.4. Business Strategies
      • 17.3.15.5. Recent Developments
    • 17.3.16. Bausch Health Companies Inc.
      • 17.3.16.1. Company Overview
      • 17.3.16.2. Financial Overview
      • 17.3.16.3. Product Portfolio
      • 17.3.16.4. Business Strategies
      • 17.3.16.5. Recent Developments